Your browser doesn't support javascript.
Lessons learnt from implementing the Good Governance for Medicines Programme in Zimbabwe.
Maponga, Charles Chiedza; Chikwinya, Takudzwa; Hove, Ropa; Madzikwa, Newman; Mazambara, Fine; Midzi, Stanley M; Mudzimu, Forward; Ndlovu, Misheck; Ngirande, William; Vengesayi, Ndanatseyi; Mhazo, Alison T.
  • Maponga CC; Pharmacy and Pharmaceutical Sciences, University of Zimbabwe, Harare, Zimbabwe cmaponga@buffalo.edu.
  • Chikwinya T; Pharmacy and Pharmaceutical Sciences, University of Zimbabwe, Harare, Zimbabwe.
  • Hove R; Independent Researcher, Harare, Zimbabwe.
  • Madzikwa N; Ministry of Health and Child Care-Directorate of Pharmacy Services, Ministry of Health and Child Care, Harare, Zimbabwe.
  • Mazambara F; Department of Pharmacy and Pharmaceutical Sciences, Centre of Excellence for Pharmaceutical Innovation (COE-PI), University of Zimbabwe, Harare, Zimbabwe.
  • Midzi SM; World Health Organization Zimbabwe Country Office, World Health Organization Regional Office for Africa, Brazzaville, Zimbabwe.
  • Mudzimu F; United Nations Development Programme (UNDP), Zimbabwe Global Fund Project, United Nations Development Programme Zimbabwe, Harare, Zimbabwe.
  • Ndlovu M; Ministry of Health and Child Care-Directorate of Pharmacy Services, Ministry of Health and Child Care, Harare, Zimbabwe.
  • Ngirande W; Department of Pharmacy and Pharmaceutical Sciences, Centre of Excellence for Pharmaceutical Innovation (COE-PI), University of Zimbabwe, Harare, Zimbabwe.
  • Vengesayi N; Department of Pharmacy and Pharmaceutical Sciences, Centre of Excellence for Pharmaceutical Innovation (COE-PI), University of Zimbabwe, Harare, Zimbabwe.
  • Mhazo AT; Ministry of Health, Ministry of Health Malawi, Lilongwe, Malawi.
BMJ Glob Health ; 7(1)2022 01.
Article in English | MEDLINE | ID: covidwho-1622049
ABSTRACT
WHO launched the Good Governance for Medicines (GGM) programme in 2004 with the aim of fighting the problem of corruption in the pharmaceutical sector. Zimbabwe adopted the GGM programme in 2015 and developed its own implementation framework (GGM-IF) in 2017 based on the WHO global guidelines and recommendations. Zimbabwe's GGM-IF emerged from; (1) home-based expertise, (2) extensive local consultations and (3) effective incorporation into existing institutions. The GGM-IF committed to implementing a focused programme over a 5-year period from 2017 to 2022 with the expressed goal of improving transparency and accountability in the pharmaceutical sector as a key enabler to improve access to medicines. Midway through its projected lifespan, some notable achievements materialised attributed to key success drivers, including mutual collaboration with the Ministry of Health and Child Care's existing Global Fund supported Quality Assurance Programme. Key challenges faced include limited funding for the programme, a shifting policy environment driven by a political transition and reorientation of priorities in the wake of the COVID-19 pandemic. This manuscript articulates 3-year operationalisation of Zimbabwe's GGM-IF highlighting the success drivers, implementation challenges and lessons learnt.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / COVID-19 Limits: Humans Country/Region as subject: Africa Language: English Year: 2022 Document Type: Article Affiliation country: Bmjgh-2021-007548

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / COVID-19 Limits: Humans Country/Region as subject: Africa Language: English Year: 2022 Document Type: Article Affiliation country: Bmjgh-2021-007548